Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Neely

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|June 2, 2025
Population pharmacokinetics of meropenem-vaborbactam in acutely ill hospitalized patients with various degrees of renal dysfunction including continuous renal replacement therapyGriffin Reed, Adrian Valadez, Brandon J Smith, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved SurvivalNathaniel J Rhodes, Joseph L Kuti, David P Nicolau, et al.
Therapeutic Drug Monitoring|July 12, 2011
CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected childrenNatella Y Rakhmanina, Michael N Neely, Ron H N Van Schaik, et al.
The Journal of Infectious Diseases|November 2, 2014
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumoniaArnold Louie, Weiguo Liu, Michael VanGuilder, et al.
Obstetrics and Gynecology|June 24, 2009
Triple-marker prenatal screening program for chromosomal defectsN Neely Kazerouni, Bob Currier, Linda Malm, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2006
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulenceHemantha Kulasakara, Vincent Lee, Anja Brencic, et al.
Pharmaceutics|January 5, 2021
An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population PharmacokineticsWalter M Yamada, Michael N Neely, Jay Bartroff, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2017
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated RatsNathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated RatsNathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2015
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxisNathaniel J Rhodes, Bradley J Gardiner, Michael N Neely, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|June 2, 2025
Population pharmacokinetics of meropenem-vaborbactam in acutely ill hospitalized patients with various degrees of renal dysfunction including continuous renal replacement therapyGriffin Reed, Adrian Valadez, Brandon J Smith, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved SurvivalNathaniel J Rhodes, Joseph L Kuti, David P Nicolau, et al.
Therapeutic Drug Monitoring|July 12, 2011
CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected childrenNatella Y Rakhmanina, Michael N Neely, Ron H N Van Schaik, et al.
The Journal of Infectious Diseases|November 2, 2014
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumoniaArnold Louie, Weiguo Liu, Michael VanGuilder, et al.
Obstetrics and Gynecology|June 24, 2009
Triple-marker prenatal screening program for chromosomal defectsN Neely Kazerouni, Bob Currier, Linda Malm, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2006
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulenceHemantha Kulasakara, Vincent Lee, Anja Brencic, et al.
Pharmaceutics|January 5, 2021
An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population PharmacokineticsWalter M Yamada, Michael N Neely, Jay Bartroff, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2017
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated RatsNathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated RatsNathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2015
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxisNathaniel J Rhodes, Bradley J Gardiner, Michael N Neely, et al.
Pageof 25